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Abstract 
Objectives: Various antibacterial and antiplaque agents are used in chemical plaque control but none are without 
their shortcomings. Chlorhexidine considered a gold standard, also has an array of side effects. To overcome these, 
numerous herbal extracts have been tried and tested and one among them is holy basil. The present study evaluated 
the antibacterial efficacy of holy basil in vitro against some periodontopathogens and its antiplaque effect in vivo.
Study Design: Thirty periodontally healthy volunteers were randomly divided into three groups and refrained from 
all mechanical oral hygiene measures for 4 days and used one of the randomly assigned mouthwash (1- chlor-
hexidine; 2- holy basil; and 3- sterile water [placebo]) twice daily. The Plaque Index (PI) was assessed at days 0 
and 5. Aqueous extract of holy basil was tested against Prevotella intermedia (P. intermedia) and Fusobacterium 
nucleatum (F.nucleatum).
Results: Holy basil extract showed inhibition of both the tested periodontopathogens (P.intermedia and F.nucleatum) 
at various concentrations. In all groups, the PI increased from baseline to day 5. There was a statistically significant 
difference (p < .05) between the chlorhexidine and placebo rinse and the holy basil and placebo rinse, but no statis-
tically significant difference was found between the chlorhexidine and holy basil rinse with respect to PI. 
Conclusions: These results indicate that the holy basil mouthwash has an antiplaque effect and is efficacious against 
P. intermedia and F. nucleatum strains in vitro. Hence holy basil mouthwash may have potential as an antiplaque 
mouthwash with prophylactic benefits.
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Introduction
Ocimum sanctum commonly known as holy basil is an 
aromatic plant in the family Labiatae. The genus Oci-
mum includes aromatic herbs yielding essential oils, and 
has tropical distribution with nearly two-third of the 160 
species reported from West Africa and the remaining 
one- third from Asia and America. India is represen-
ted by nine species of Ocimum, among which Ocimum 
sanctum is most prevalent (1). Holy basil is cultivated 
for religious and medicinal purposes, and for its essen-
tial oil. 
The leaves of holy basil contain 0.7% volatile oil compri-
sing about 71% eugenol and 20% methyl eugenol. The 
oil also contains carvacrol and sesquiterpine hydrocar-
bon caryophyllene. Fresh leaves and stem of holy basil 
extract yielded some phenolic compounds [antioxidants] 
such as cirsilineol, circimaritin, isothymusin, apigenin 
and rosameric acid, and appreciable quantities of eu-
genol. Two flavonoids, viz., orientin and vicenin from 
aqueous leaf extract of holy basil have been isolated. Ur-
solic acid, apigenin, luteolin, apigenin-7-O-glucuronide, 
luteolin-7-O glucuronide, orientin and molludistin have 
also been isolated from the leaf extract. Holy basil also 
contains a number of sesquiterpenes and monoterpenes 
viz., bornyl acetate, β -elemene, neral, camphene, cam-
pesterol, cholesterol and stigmasterol (2).
A variety of in vitro and in vivo studies have indicated 
some potential pharmacological properties of holy basil 
and its extracts. The anticancer activity of holy basil has 
been proved and cited by several investigators. The al-
coholic extract of leaves of holy basil has a modulatory 
influence on carcinogen metabolizing enzymes such as 
cytochrome P 450, glutathione S-transferase [GST] etc., 
which are important in detoxification of carcinogens and 
mutagens. β-elemene, a constituent of holy basil has 
been studied for its potential anticancer properties, but 
human clinical trials have yet to confirm its effective-
ness (3).
The antioxidant activity of holy basil has been reported 
by many workers and holy basil renders protection from 
radiation poisoning and can repair cells damaged by ex-
posure to radiation (4). The fixed oil has demonstrated 
anti-hyperlipidemic and cardioprotective effects in rats 
fed a high fat diet (5).  A double-blind trial conducted by 
Mondal S et al. [2011] (6) suggested that an alcoholic 
extract of holy basil modulates immunity, thus promo-
ting immune system function. The essential oil of holy 
basil significantly possessed antiulcer activity due to its 
lipoxygenase inhibitory, histamine antagonistic and an-
tisecretory effects (7).
Methanolic extract  and aqueous suspension of holy ba-
sil showed analgesic, antipyretic and antiinflammatory 
effects in acute and chronic inflammations in rats (8) 
and according to a recent study  holy basil acts a COX-2 
inhibitor, proving its anti-inflammatory property (1). 
The other properties of holy basil includes, antibacterial 
property, hepatoprotective, antifertility, antiarthritic and 
anticoagulant activity (2).
Among all the properties of holy basil described, its an-
ti-inflammatory action, bacteriostatic effect, antioxidant 
and immune modulatory properties make its use as a 
therapeutic agent for gingival and periodontal disease an 
appealing proposition. Hence, the aim of the present stu-
dy was to evaluate the antibacterial and antiplaque effi-
cacy of holy basil containing mouthwash in comparison 
with 0.2% chlorhexidine and sterile water as placebo.
Material and Methods 
- Study design:
The present study was carried out between January and 
February 2013 in this institution, and was divided into 
two parts. First, the aqueous extract of holy basil was 
prepared and antibacterial activity of holy basil ex-
tract was assessed by evaluating the minimum inhibi-
tory concentration [MIC] against two periodontopathic 
organisms: Fusobacterium nucleatum [F. nucleatum], 
ATCC 25586 and Prevotella intermedia [P. intermedia] 
ATCC 25611. Second, a single-blinded, parallel design, 
clinical study was carried out and the 4-day plaque re-
growth model was used to study the efficacy of the three 
mouthwashes.
- Test products:
The products used in the present study were [i] Holy ba-
sil mouthwash, [ii] Commercially available chlorhexi-
dine [0.2%] mouthwash [Rexidin mouthwash, Indoco 
Remedies Ltd, Mumbai, India.] and [iii] Sterile water 
[Claris life sciences Ahmedabad, India.]
All of the three mouthwashes were dispensed in similar-
looking opaque bottles.
- Preparation of holy basil mouthwash: 
Preparation of aqueous extract of holy basil and prepara-
tion of the mouthwash was carried out in Department of 
Biochemistry, S.D.M. College of Medical Sciences and 
Hospital, Dharwad, Karnataka, India.
Dry leaves of holy basil were crushed to prepare a fine 
paste. Fifty grams of fine paste was added to 100 mL 
distilled water. The mixture of paste and distilled water 
were homogenized with a high speed blender. Care was 
taken to maintain the temperature below 150 C by pro-
viding cold water bath. One hundred mL distilled water 
was added and once again subjected to homogenization. 
The homogenized paste thus obtained was then filtered 
with muslin cloth by squeezing. Thirty three grams of 
remnant leaves paste was discarded. Two hundred and 
forty two ml of liquid extract was obtained after the abo-
ve procedure. The liquid extract was then centrifuged at 
5000 rpm for 10 min at 60 C to remove any suspended 
particles. The supernatant was collected in a sterile glass 
container and stored at refrigerated condition.
This aqueous extract contained 14 gm% extract from the 
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paste and was considered as 100% extract for MIC ac-
tivity. Further dilutions were prepared from the above 
100% extract and MIC activity was analysed. For pre-
paration of the mouthwash, distilled water was added to 
the 14 gm% aqueous extract to obtain 3.5gm% solution 
which was used to test the anti plaque efficacy in vivo.
- Evaluation of Minimum Inhibitory Concentration:
Minimum inhibitory concentration [MIC] is defined as 
the lowest concentration of an antimicrobial that will 
inhibit the visible growth of a microorganism after over-
night incubation (9).
MIC of the holy basil extract was evaluated by broth di-
lution method against two periodontopathic organisms: F. 
nucleatum ATCC 25586 and P. intermedia ATCC 25611, to 
determine its antibacterial activity. Various dilutions of the 
holy basil extract [500 mg/mL, 250 mg/mL, 125 mg/mL, 
62.5 mg/mL, 31.25 mg/mL,16.125 mg/mL, 8 mg/mL, 4 
mg/mL, 2 mg/ mL, and 1 mg/mL] was tested against these 
organisms. Various dilutions of the holy basil extract and 
the organism to be tested was incubated in brain heart infu-
sion agar for 24 hours and observed for turbidity.
- Clinical evaluation:
The design of the present study was in accordance with 
the Declaration of Helsinki and was approved by the 
Ethical Committee of this institution.
Thirty volunteers – 17 males and 13 females [age: 18 to 
22 years] were recruited in the present study. These vo-
lunteers were students of this institution. Details of the 
present study were explained, and informed consent was 
obtained from the volunteers. Exclusion criteria inclu-
de consumption of antibiotics or other medication in the 
last 3 months that might interfere with plaque formation, 
< 20 teeth to be included in the evaluation, presence of 
crowns or restorations, extensive bridges or prosthetic 
constructions and orthodontic appliances, known intole-
rance or allergy to mouthwashes, age below 18 years [18 
years is the legal age in India to give informed consent 
without the permission of a parent/guardian] and preg-
nant women or lactating mothers.
On day 1, the Turesky et al. [1970] (10) modification 
of Quigley and Hein [1962] (11) Plaque Index using a 
3% erythrosine dye [Agent P, ICPA Health Products Ltd, 
Mumbai, India.] was recorded. Using this index, plaque 
was assessed on the buccal/labial and lingual/palatal sur-
faces of all teeth.
The scoring criteria employed were as follows:
0 = No plaque.
1 = Separate flecks of plaque at the cervical margin of 
the tooth.
2 = A thin continuous band of plaque [up to 1 mm] at the 
cervical margin of the tooth.
3 = A band of plaque wider than 1 mm at the cervical 
margin of the tooth.
4 = Plaque covering at least one-third but less than two-
thirds of the crown of the tooth.
5 = Plaque covering two-thirds or more of the crown of 
the tooth.
These indices were recorded by two trained and calibra-
ted examiners [MHD and CV] who were blinded to the 
mouthwashes administered. Calibration was performed 
on three subjects, not included in the present study, and 
the ensuing scores were analysed by a third examiner. 
Scaling was performed by the same two calibrated exa-
miners on all of the subjects recruited in the present stu-
dy such that the areas stained with the disclosing agent 
were completely cleaned, to ensure zero plaque index 
scores. The baseline plaque index scores were calculated 
before scaling.
Volunteers were randomly allocated to one of the three 
groups, ten in each group. Group 1 [positive control] 
was the chlorhexidine group, Group 2 [test] was the 
holy basil group and Group 3 [negative control] was the 
sterile water group. For the following 4 test days, the vo-
lunteers had to refrain from carrying out all mechanical 
oral hygiene measures. Chewing gum was similarly not 
allowed. Instead, each volunteer rinsed for 1 min, twice 
daily [in the morning and evening after eating] with 10 
ml of randomly allocated mouthwash solution.
The rinsing was monitored on all occasions by the exa-
miners. The dietary regime of the patients was not al-
tered, but it was ensured that the patients had a similar 
diet.
On day 5, the indices were re-recorded, and the volun-
teers were allowed to reinstate their routine oral hygiene 
procedures. These scores were the plaque re-growth sco-
res which were subjected to statistical analysis.
Statistical Evaluation
After the completion of re-recording of indices and de-
coding the mouthwash order, further evaluation was per-
formed with the computer program Statistical Package 
for the Social Sciences [SPSS] version 11.0. The p value 
was set at ≤ 0.05. The mean plaque re-growth was calcu-
lated for each rinse solution. The normal distribution of 
the test data for each rinse solution and the differences 
compared to the placebo were checked with the Kolmo-
gorov-Smirnov test and Shapiro Wilk test. Difference in 
the mean values between groups both at the base line and 
day 5 was determined by ANOVA followed by Tukey’s 
test for pair wise comparison. The paired t-test was used 
to test whether there was any significant difference bet-
ween mean PI scores at baseline and day 5.
Results
The in vitro study that was conducted for MIC evalua-
tion showed that both the tested periodontopathogens [P. 
intermedia and F. nucleatum] were susceptible to holy 
basil extract at all the concentrations tested ranging from 
10-1 to 10-9 suggesting a very high antibacterial activity.
Thirty subjects, 17 males and 13 females, completed the 
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study. ANOVA [with p ≤ 0.05] showed no significant di-
fference between mean of PI scores in the three groups 
at base line [p = 0.364]. In all the groups, PI showed sig-
nificant increases from baseline to day 5 and there was a 
significant difference between mean of PI scores in the 
three groups on day 5 [p = 0.01]. The in vivo results 
showed that the mean difference in PI values from base-
line to day 5 were highest for the placebo rinse [-0.8070] 
and the lowest for chlorhexidine [-0.2800]. The mean 
difference in PI value for holy basil [0.6880] was higher 
than chlorhexidine. The paired t test showed a statisti-
cally significant increase in the PI with holy basil [p = 
0.04] and placebo [p = 0.01] as compared to chlorhexi-
dine [p = 0.177] (Table 1).
Sample Mean of PI at 
baseline
Mean of PI at 
day 5
Mean difference from 
baseline to day 5
SD P-value
Chlorhexidine 1.6970 1.9770 -0.2800 0.60413 0.177
Holy basil 1.6310 2.3190 -0.6880 0.27563 0.04*
Placebo 1.9220 2.7290 -0.8070 0.49780 0.01*
p ≤ 0.05
* Significant
PI – Plaque index
SD – Standard deviation
Table 1. Results of in vivo plaque index comparing the mean PI scores of Baseline and Day 5 using paired t-test.
Differences between the individual rinse solutions and 
the placebo solution, determined via the Tukey Post hoc 
test, demonstrated significantly less plaque regrowth 
with respect to both chlorhexidine [p = 0.007] and holy 
basil [p = 0.041] as compared to the placebo. The di-
fference between chlorhexidine and holy basil was not 
statistically significant [p = 0.187], suggesting the two 
rinses at the 95% confidence interval have a similar cli-
nical efficacy.
Discussion
Periodontal disease is a chronic inflammatory disease 
characterized by loss of connective tissue, alveolar bone 
resorption, and formation of periodontal pockets as a re-
sult of the complex interaction between pathogenic bac-
teria and the host’s immune response. Periodontitis starts 
as gingival inflammation mainly due to the presence of 
bacterial plaque, which, if left untreated, may progress 
and eventually lead to destruction of the entire perio-
dontal attachment apparatus of the affected teeth (12). 
Prevention of periodontal disease should be based on the 
measures of supragingival plaque control thereby pre-
venting gingivitis. Antibacterial measures such a good 
oral hygiene with or without chemotherapeutic agents, 
will diminish the plaque mass and reduce the injurious 
load on the tissues (13). Efficacy of mechanical plaque 
control in removing the bacterial plaque is well docu-
mented (14). But De La Rosa et al [1979] (15) showed 
that only half of the plaque was removed with brushing 
for 2 min. Rugg-Gunn and MacGregor [1978] (16) and 
MacGregor and Rugg-Gurm [1979] (17) suggested that 
certain tooth surfaces receive little or no attention during 
the brushing cycle. In combination with toothbrushing, 
daily use of the tested mouthwashes may result in a hig-
her interproximal plaque reduction than daily flossing 
(18). Adjunctive use of chemicals would therefore appear 
to be a way of overcoming deficiencies in mechanical 
tooth cleaning habits. Among all of the anti-plaque and 
anti-gingivitis agents available, chlorhexidine continues 
to remain the ‘gold standard’ (19). However, it comes 
at the cost of several side effects. Hence, its long term 
use is not advocated. Excluding chlorhexidine contai-
ning rinses, only essential oil-containing rinse has been 
extensively evaluated and subsequently been shown to 
be of value as an adjunct to mechanical oral procedures 
(20,21). However, the alcohol content of essential oil 
rinses and its unpleasant taste are unacceptable to a few 
patients. Hence, the quest for a long-term, ideal and safe, 
anti-plaque and anti-gingivitis agent still continues.
The field of medicine is increasingly receptive to the use 
of antimicrobials derived from plant sources, as traditio-
nal antimicrobial agents become ineffective against both 
existing and new microbial diseases. The increasing 
problems of resistance to synthetic antimicrobials have 
encouraged the search for alternative natural products. 
Plants are the source of more than 25% of prescriptions 
and over-the-counter preparations, and the potential of 
natural agents for oral prophylaxis can therefore be con-
sidered (22).
The present short term study aimed to evaluate the anti-
bacterial property of aqueous extract of holy basil against 
two periodonto pathogens in vitro and antiplaque effica-
cy in vivo. To evaluate the antiplaque efficacy, a four 
day plaque regrowth model was used. This study design 
can be described as an established method for testing the 
plaque inhibiting effect of an oral hygiene product as it 
used by numerous investigators (23-25). The advantage 
of four day plaque regrowth study design is that it elimi-
nates the effect of adjunctive mechanical oral hygiene 
practices as they were not allowed during the study pe-
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riod. According to our knowledge, this is the first study 
to evaluate the antibacterial activity of holy basil against 
the periodonto pathogens [P. intermedia and F. nuclea-
tum] in vitro and antiplaque efficacy in vivo.
Antimicrobial activity of holy basil extract was evalua-
ted by various authors. Aqueous extract of holy basil 
showed growth inhibition for Klesbiella, Escherecia 
coli, Proteus and Staphylococcus aureus while alcoholic 
extract showed growth inhibition for Vibrio cholerae. 
The alcoholic extract was also found to be active against 
multidrug-resistant strains of S. aureus that are also re-
sistant to common beta lactam antibiotics. Holy basil es-
sential oil showed good antibacterial activity against Ba-
cillus pumilus, Pseudomonas aeruginosa and S. aureus 
and higher content of linolenic acid in holy basil essen-
tial oil could contribute towards its antibacterial activity 
(26). In the dental literature, only one such study carried 
out by Agarwal et al. [2010] (26) is available in which 
antibacterial activity of various concentrations of holy 
basil extract was evaluated in vitro against Streptococ-
cus mutans and they observed that at 4% concentration, 
holy basil showed the highest antibacterial activity.
The antioxidant activity of holy basil is one of the rea-
sons for its widespread application in various fields of 
medicine. The antioxidant properties of flavonoids and 
their relation to membrane protection have been obser-
ved. Antioxidant activity of the flavonoids [orientin and 
vicenin] in vivo was expressed in a significant reduction 
in the radiation induced lipid peroxidation in mouse li-
ver. Holy basil extract has significant ability to scavenge 
highly reactive free radicals. The phenolic compounds 
like cirsilineol, apigenin and rosmarinic acid, and euge-
nol from extract of fresh leaves and stems of holy basil 
possessed good antioxidant activity (27).
Methanolic extract and aqueous suspension of holy ba-
sil showed analgesic, antipyretic and antiinflammatory 
effects. To ascertain the inhibitory effect of holy basil 
essential oil on various mediators of inflammation, the 
antiinflammatory effect of the oil was evaluated against 
histamine, serotonin, bradykinin, and PGE2-induced 
paw edema in rats. The oil significantly inhibited ede-
ma formation induced by the inflammatory mediators. 
The fixed oil and linolenic acid possess significant an-
tiinflammatory activity against PGE2, leukotriene and 
arachidonic acid induced paw oedema in rats by virtue 
of their capacity to block both the cyclooxygenase and 
lipoxygenase pathways of arachidonic acid metabolism. 
However essential oil was found to be devoid of analge-
sic activity in experimental pain models (2).
The results of the present study showed that holy basil-
containing mouthwash was comparable to chlorhexidine 
with respect to its anti-plaque action with no statistically 
significant difference between the two.
The plaque inhibitory effect of holy basil mouth rinse 
can be attributable to its ability to kill dental plaque bac-
teria which can be correlated with the results of the in 
vitro study which comprised of evaluating antibacterial 
activity of holy basil extract against the two proven pe-
riodontopathogens P. intermedia and F. nucleatum. Re-
sults showed that both the organisms were sensitive to 
holy basil at all the concentrations tested [10 -1 to 10 -9 
dilution], suggesting a potential antibacterial activity.
The limitations of the present study include the short 
time frame of the study, due to which the effect of the 
three mouthwashes on gingival inflammation could not 
be evaluated. Also, the parallel design of the present stu-
dy could have affected the results, as every individual 
has a different rate of plaque growth. The anti-inflamma-
tory and antioxidant action of holy basil has been cited 
in the literature. This was a coherent attempt to study 
its antibacterial and anti-plaque action. The potential 
strategies to harness these actions of holy basil could be 
supragingivally in the form of a mouthwash or a gel and 
subgingivally, in the form of irrigation or local drug de-
livery system.
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